HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1

NCT ID: NCT00084175

Last Updated: 2017-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

630 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-04-30

Study Completion Date

2005-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behavior Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Primary Study Purpose

TREATMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavior Therapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Washington

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Donald Calsyn, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Matrix Institute on Addictions

Rancho Cucamonga, California, United States

Site Status

San Francisco General Hospital

San Francisco, California, United States

Site Status

Hartford Dispensary

New Britain, Connecticut, United States

Site Status

CT Renaissance, Inc.

Norwalk, Connecticut, United States

Site Status

Life Link

Santa Fe, New Mexico, United States

Site Status

Staten Island University Hospital

Staten Island, New York, United States

Site Status

Addiction Drug Services-Highpoint

High Point, North Carolina, United States

Site Status

South Light

Raleigh, North Carolina, United States

Site Status

Comprehensive Addiction Services System

Toledo, Ohio, United States

Site Status

The Consortium

Philadelphia, Pennsylvania, United States

Site Status

Thomas Jefferson Intensive Sub. Abuse TP

Philadelphia, Pennsylvania, United States

Site Status

LRADAC-Lexington-Richmond Alcohol & Drug Council

Columbia, South Carolina, United States

Site Status

Evergreen Treatment Services

Seattle, Washington, United States

Site Status

Prestera Center for Mental Health Svcs.

Huntington, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Calsyn DA, Campbell AN, Tross S, Hatch-Maillette MA. Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations. Am J Drug Alcohol Abuse. 2011 Sep;37(5):294-300. doi: 10.3109/00952990.2011.596874.

Reference Type DERIVED
PMID: 21854271 (View on PubMed)

Calsyn DA, Crits-Christoph P, Hatch-Maillette MA, Doyle SR, Song YS, Coyer S, Pelta S. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction. 2010 Jan;105(1):100-8. doi: 10.1111/j.1360-0443.2009.02812.x.

Reference Type DERIVED
PMID: 20078464 (View on PubMed)

Calsyn DA, Hatch-Maillette M, Tross S, Doyle SR, Crits-Christoph P, Song YS, Harrer JM, Lalos G, Berns SB. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. J Subst Abuse Treat. 2009 Sep;37(2):138-50. doi: 10.1016/j.jsat.2008.11.008. Epub 2009 Jan 15.

Reference Type DERIVED
PMID: 19150206 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIDA-CTN-0018-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Development of a Methamphetamine Early Intervention
NCT01174654 COMPLETED PHASE1/PHASE2